A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
We use cookies primarily to enhance your user experience and to analyze our web traffic. For more information, see our Privacy Policy. You can manage your cookie preferences in your browser’s privacy settings.